Revance Therapeutics, Inc. (RVNC)
Feb 6, 2025 = RVNC was delisted (reason: acquired by Crown Laboratories)
3.650
0.00 (0.00%)
Inactive · Last trade price on Feb 6, 2025
Revance Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -184.44 | -323.99 | -356.42 | -281.31 | -282.09 | -159.43 |
Depreciation & Amortization | 6.08 | 13.69 | 39.15 | 19.85 | 10.25 | 2.91 |
Other Amortization | 4.27 | 2.4 | 1.88 | 1.25 | 10.73 | - |
Asset Writedown & Restructuring Costs | - | 93.18 | 69.79 | - | 11.18 | - |
Loss (Gain) From Sale of Investments | -6.3 | -6.44 | -2.18 | 0.09 | -1.42 | -2.64 |
Stock-Based Compensation | 28.21 | 47.81 | 52.34 | 43.43 | 36.45 | 17.92 |
Other Operating Activities | 1.08 | 0.65 | 1.23 | -0.08 | -3.58 | 0.8 |
Change in Accounts Receivable | -22.85 | -16.34 | -7.99 | -1.52 | -1.74 | 27 |
Change in Inventory | -7.14 | -14.91 | -6.01 | -4.28 | -5.88 | - |
Change in Accounts Payable | 4.74 | 6.9 | -5.45 | -1.82 | 4.43 | -0.36 |
Change in Unearned Revenue | 2.19 | -4.29 | 1.93 | -1.63 | 29.29 | 4.59 |
Change in Other Net Operating Assets | -16.74 | -15.25 | 18.18 | 4.48 | 13.87 | 3.05 |
Operating Cash Flow | -190.89 | -216.58 | -193.55 | -221.54 | -178.5 | -106.16 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Capital Expenditures | -4.02 | -6.89 | -3.21 | -10.38 | -4.1 | -3.23 |
Cash Acquisitions | - | - | - | - | -0.82 | - |
Sale (Purchase) of Intangibles | - | - | - | - | -0.12 | - |
Investment in Securities | 1.72 | 121.51 | -115.79 | -11.59 | 17.17 | -14.36 |
Other Investing Activities | -10.63 | -4.88 | -19.8 | -7.7 | - | - |
Investing Cash Flow | -12.94 | 109.74 | -138.8 | -29.67 | 12.13 | -17.59 |
Financing Activities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Long-Term Debt Issued | - | 48.42 | 98.15 | - | 287.5 | - |
Long-Term Debt Repaid | - | -18.26 | -11.1 | - | - | - |
Net Debt Issued (Repaid) | -16.58 | 30.16 | 87.05 | - | 287.5 | - |
Issuance of Common Stock | 99.47 | 115.47 | 252.83 | 38.39 | 90.84 | 223.78 |
Repurchase of Common Stock | -0.68 | -8.22 | -6.5 | -8.19 | -8.44 | -1.38 |
Other Financing Activities | -0.51 | -0.85 | -1.7 | -0.34 | -38.42 | -0.74 |
Financing Cash Flow | 81.7 | 136.57 | 331.69 | 29.87 | 331.48 | 221.66 |
Net Cash Flow
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Cash Flow | -122.13 | 29.73 | -0.65 | -221.33 | 165.11 | 97.9 |
Free Cash Flow
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Free Cash Flow | -194.91 | -223.46 | -196.76 | -231.91 | -182.6 | -109.39 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -75.86% | -95.48% | -148.42% | -298.10% | -1191.52% | -26486.93% |
Free Cash Flow Per Share | -2.02 | -2.64 | -2.71 | -3.44 | -3.15 | -2.52 |
Levered Free Cash Flow | -167.85 | -134.99 | -94.99 | -122.96 | -112.54 | -54.02 |
Unlevered Free Cash Flow | -157.71 | -125.29 | -86.58 | -120.29 | -113.79 | -54.02 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash Interest Paid | 15.09 | 15.09 | 12.23 | 5.03 | 2.53 | - |
Cash Income Tax Paid | 0.3 | 0.3 | 0.7 | - | 0.1 | 3 |